In the past one year, the Nifty Pharma Index has shed 12.4% as against the 1% gains in the benchmark Nifty 50. Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an average, according to Value Research.
eMudhra shares crash another 4%, down 40% in 3 sessions. What’s behind this free fall?
eMudhra will exit its global SSL/TLS certificate business following a security incident involving compromised private keys linked to eight intermediate Certificate Authority certificates. The segment